Research
Metabolic adaptation
Tirzepatide and semaglutide exceeded 10% total body weight loss and showed the most favorable glycaemic effects.
Tirzepatide and semaglutide may be prioritized for patients needing significant weight loss and glycaemic control.
StrongSupportsmedium confidence
Tirzepatide and semaglutide exceeded 10% TBWL and showed the most favourable glycaemic effects.
Why this rating
Based on the systematic review and meta-analysis of randomized controlled trials.
Source
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults: 2026 Update
Andreea Ciudin Mihai et al. · medRxiv · 2026
Meta-analysisCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →